Hanlim Pharm. Co., Ltd. — CureCurrent

Published trials20

Recruiting shown1

Roles2

SourceClinicalTrials.gov

Clinical trials

20 shown

Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes MellitusNCT07552389 · lead sponsor · 2025-12-18

Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting StateNCT07568652 · lead sponsor · 2024-10-16

Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult VolunteersNCT07598968 · lead sponsor · 2023-06-18

Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary DiseaseNCT06434792 · lead sponsor · 2023-06-01

S-amlodipine in Essential HypertensIon and Assessment of Blood Pressure Targets AchievementNCT06130124 · lead sponsor · 2023-02-22

The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR TabNCT06188234 · lead sponsor · 2022-12-27

DEXINEURO® Tab on Blood Glucose Reduction in Patients With Type 2 Diabetes Accompanied by Diabetic Peripheral NeuropathyNCT06191614 · lead sponsor · 2022-05-19

An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)NCT06214832 · lead sponsor · 2021-11-11

Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer PatientsNCT04632342 · lead sponsor · 2020-11-01

Phase 2a Clinical Trial of HL237 for Rheumatoid ArthritisNCT04638426 · lead sponsor · 2020-09-10

To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary HypercholesterolemiaNCT04659070 · lead sponsor · 2020-07-15

Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult VolunteersNCT04667624 · lead sponsor · 2020-02-29

A Multiple Dose of HL237 in Healthy Male SubjectNCT03896594 · lead sponsor · 2018-12-24

A Single Ascending Dose Clinical Trial to Find the Maximum Tolerable Dose of HL237 in Healthy Male SubjectNCT03278470 · lead sponsor · 2017-06-26

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)NCT03648333 · lead sponsor · 2013-12-01

Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma PatientsNCT06078605 · collaborator · 2022-09-16

Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular HypertensiveNCT06078592 · collaborator · 2021-10-08

Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center TrialNCT04647461 · collaborator · 2019-03-20

S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in HypertensionNCT03226340 · collaborator · 2015-12-02

A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon®NCT03962296 · collaborator · 2012-11-21

Sponsor roles

lead sponsor15

collaborator5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.